MCID: PRN029
MIFTS: 28

Parainfluenza Virus Type 3 malady

Category: Rare diseases

Aliases & Classifications for Parainfluenza Virus Type 3

About this section

Aliases & Descriptions for Parainfluenza Virus Type 3:

Name: Parainfluenza Virus Type 3 45
Human Parainfluenza Virus Type 3 45
 
Piv3 45

Classifications:



Summaries for Parainfluenza Virus Type 3

About this section
MalaCards based summary: Parainfluenza Virus Type 3, also known as human parainfluenza virus type 3, is related to fetal parainfluenza virus type 3 syndrome and hepatitis. An important gene associated with Parainfluenza Virus Type 3 is NEU1 (Neuraminidase 1 (Lysosomal Sialidase)), and among its related pathways is Hepatitis C. Affiliated tissues include bone, brain and lung.

Related Diseases for Parainfluenza Virus Type 3

About this section

Graphical network of the top 20 diseases related to Parainfluenza Virus Type 3:



Diseases related to parainfluenza virus type 3

Symptoms for Parainfluenza Virus Type 3

About this section

Drugs & Therapeutics for Parainfluenza Virus Type 3

About this section

Drugs for Parainfluenza Virus Type 3 (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 14)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Ergocalciferolapproved, nutraceuticalPhase 392350-14-65280793
Synonyms:
'Ergosterol irradiated'
(+)-Vitamin D2
(3-beta,5Z,7E,22E)-9,10-Secoergosta-5,7,10,(19),22-tetraen-3-ol
(3S,5Z,7E,14xi,17alpha,22E)-9,10-secoergosta-5,7,10,22-tetraen-3-ol
(3S,5Z,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol
(3S,5Z,7E,22E)-9,10-secoergosta-5,7,10,22-tetraen-3-ol
(3beta,5Z,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol
(3beta,5Z,7e,22e)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol
(5E,7E,22E)-9,10-Secoergosta-5,7,10,22-tetraen-3-ol
(5Z,7E,22E)-(3S)-9,10-seco-5,7,10(19),22-ergostatetraen-3-ol
(5Z,7E,22E)-(3S)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol
(5Z,7e,22e)-(3S)-9,10-Seco-5,7,10(19),22-ergostatetraen-3-ol
(5Z,7e,22e)-(3S)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol
22-Tetraen 3beta 9,10,Secoergosta-5,7,10(19)-ol
31316-19-5
4-Methylene-3-[2-[tetrahydro-7a-methyl-1-(1,4,5-trimethyl-2-hexenyl)-4(3aH)-indanylidene]ethylidene]-Cyclohexanol
47768_SUPELCO
50-14-6
7489-18-1
7E677DC1-E1C4-4FC5-8F4A-BCE1857F7E87
8017-28-5
9,10,Secoergosta-5,7,10(19),22-tetraen 3.beta.-ol
9,10-Seco(5Z,7E,22E)-5,7,10(19),22-ergostatetraen-3-ol
9,10-Secoergosta-5,7,10(19),22-tetraen-3-beta-ol
9,10-Secoergosta-5,7,10(19),22-tetraen-3b-ol
95220_FLUKA
95220_SIGMA
AC-1355
AC1L1FIE
AC1NQXLH
AC1NS4DE
AC1NS9GI
AC1NSSVD
AC1NWAM3
AC1O5EDK
AC1O6WAM
ACon1_002187
Activated ergosterol
BPBio1_000418
BSPBio_000380
BSPBio_001974
Buco-D
C05441
C28H44O
CALCIFEROL IN A GELATIN MATRIX
CALCIFEROL, U.S.P.
CHEBI:28934
CHEMBL1536
CID11003810
CID3249
CID5280793
CID5315257
CID5353610
CID5356615
CID5702050
CID6432478
CID6536972
Calciferol
Calciferol (TN)
Calciferol (vitamin D2)
Calciferolum
Calciferon 2
Condacaps
Condocaps
Condol
Crtron
Crystallina
D-Arthin
D-Tracetten
D00187
DB00153
Daral
Davitamon D
Davitin
De-rat concentrate
Decaps
Dee-Osterol
Dee-Ron
Dee-Ronal
Dee-Roual
Deltalin
Deratol
Detalup
Diactol
Divit urto
Doral
Drisdol
Drisdol (TN)
E5750_SIGMA
EINECS 200-014-9
Ercalciol
Ergocalciferol
Ergocalciferol (D2)
Ergocalciferol (JP15/USP)
Ergocalciferol [INN:BAN:JAN]
Ergocalciferol oil
Ergocalciferol: Vitamin D
 
Ergocalciferolo
Ergocalciferolo [DCIT]
Ergocalciferols
Ergocalciferolum
Ergocalciferolum [INN-Latin]
Ergorone
Ergosterol activated
Ergosterol irradiated
Ergosterol, irradiated
Ertron
Fortodyl
Geltabs
Geltabs Vitamin D
HMS1920K20
HMS2091B19
HMS502I07
HSDB 819
Haliver
Hi-Deratol
Hyperkil
I05-0022
IDI1_000805
Infron
Irradiated ergosta-5,7,22-trien-3-beta-ol
Irradiated ergosta-5,7,22-trien-3.beta.-ol
Irradiated ergosta-5,7,22-trien-3beta-ol
Irradiated ergosterol
LMST03010001
LMST03010014
LS-3228
MEGxm0_000466
MLS001332467
MLS001332468
Metadee
Mina D2
MolPort-001-740-057
MolPort-001-793-930
MolPort-002-526-645
MolPort-003-666-178
MolPort-006-822-629
Mulsiferol
Mykostin
NCGC00142497-01
NCGC00179579-01
NCGC00179579-02
NSC 62792
NSC62792
Novovitamin-D
Oleovitamin D
Oleovitamin D, Synthetic
Oleovitamin D2
Osteil
Ostelin
Prestwick3_000420
Prestwick_554
Radiostol
Radstein
Radsterin
Rodine C
Rodinec
SMR000857106
SPECTRUM1500276
ST057150
STOCK1N-53397
Shock-ferol
Shock-ferol sterogyl
Sorex C.R
Sorex C.R.
Spectrum5_000666
Sterogyl
Synthetic Vitamin D
UNII-VS041H42XC
Uvesterol D
Uvesterol-D
VITAMIN D2
VITAMIN D2 WATER DISPERSABLE U.S.P.
VITAMIN_D2
Vigantol
Vio D
Vio-D
Viostdrol
Viosterol
Viosterol in Oil
Vitamin D
Vitamin D2
Vitamin- D2
Vitamin-?D2
Vitamina D2
Vitavel-D
WLN: L56 FYTJ A1 BY1&1U1Y1&Y1&1 FU2U- BL6YYTJ AU1 DQ
ZINC04474571
ZINC04629876
beta-Ol
bmse000510
component of Geltabs Vitamin D
delta-Arthin
delta-Tracetten
ergocalciferol
vitamin d-2
2
Cholecalciferolapproved, nutraceuticalPhase 379967-97-06221, 10883523, 5280795
Synonyms:
()-Vitamin D3
(+)-Vitamin D3
(+)-vitamin D3
(1S,3Z)-3-[(2e)-2-[(1R,3AR,7as)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidene-cyclohexan-1-ol
(3S,5Z,7E)-9,10-secocholesta-5,7,10(19)-trien-3-ol
(3beta,5Z,7E)-9,10-secocholesta-5,7,10(19)-trien-3-ol
(3beta,5Z,7e)-9,10-Secocholesta-5,7,10(19)-trien-3-ol
(3beta,Z,7E)-9,10-Secocholesta-5,7,10(19)-trien-3-ol
(5E,7E)-9,10-Secocholesta-5,7,10-trien-3-ol
(5Z,7E)-(3S)-9,10-seco-5,7,10(19)-cholestatrien-3-ol
(5Z,7E)-(3S)-9,10-secocholesta-5,7,10(19)-trien-3-ol
(5Z,7e)-(3S)-9,10-Secocholesta-5,7,10(19)-trien-3-ol
1406-16-2
25(OH)D
3-beta,Z,7E-9,10-Secocholestr-5,7,10(19)-trien-3-ol
47763_SUPELCO
57651-82-8
67-97-0
7-Dehydrocholesterol activated
7-Dehydrocholesterol, Activated
7-Dehydrocholesterol, irradiated
7-Dehydrocholestrol, activated
8024-19-9
8050-67-7
89193_FLUKA
9,10-Seco(5Z,7E)-5,7,10(19)-cholestatrien-3-ol
9,10-Seco(5Z,7E)-5,7,10(19)-cholestatrien-3beta-ol
9,10-Secocholesta-5(Z),7(E),10(19)-trien-3(.beta.)-ol
9,10-Secocholesta-5,7,10(19)-trien-3-beta-ol
9,10-Secocholesta-5,7,10(19)-trien-3-ol
9,10-Secocholesta-5,7,10-trien-3-ol
AB1002422
AC-11697
AC1L1ECK
AC1L1M23
AC1LU7IZ
AC1NQXLN
AC1NR2UO
AC1NR2UR
AC1NR2UU
AC1NS4AJ
AC1NSHJX
AC1O5EOF
AC1O7GAV
AC1O7GQ3
AC1O8FEU
AC1O8PWJ
AC1OF2GI
AC1OF2GL
AC1OIEW5
AC1OIEWB
ACon1_001997
Activated 7-dehydrocholesterol
Arachitol
BPBio1_000460
BSPBio_000418
BSPBio_002408
Bio-0845
C05443
C1357_SIAL
C27H44O
C9756_SIGMA
C9774_SIAL
CAS-67-97-0
CC
CCRIS 5813
CCRIS 6286
CHEBI:283119
CHEBI:28940
CHEMBL1042
CHEMBL432780
CID10000117
CID10045875
CID10340013
CID10883523
CID10894379
CID11014566
CID11025493
CID11058152
CID11463269
CID1548921
CID2735
CID5280795
CID5283710
CID5283711
CID5283712
CID5353527
CID5363362
CID6221
CID6432644
CID6604201
CID6604662
CID6708595
CID6713938
CID6992015
CID6992016
CID7067439
CID7067440
CID7251172
CID7251174
CID9821465
Calciol
Cholecalciferol
Cholecalciferol (D3)
Cholecalciferol (JP15/USP)
Cholecalciferol D3
Cholecalciferol [USAN:BAN:JAN]
Cholecalciferol, D3
Cholecalciferolum
 
Colecalciferol
Colecalciferol (INN)
Colecalciferolo
Colecalciferolo [DCIT]
Colecalciferolum
Colecalciferolum [INN-Latin]
Colecalcipherol
D00188
D3-Vicotrat
D3-Vigantol
DB00169
Delsterol
Delta-D
Delta-D (TN)
Deparal
Devaron
DivK1c_006276
Duphafral D3 1000
EINECS 200-673-2
EINECS 215-797-2
EPA Pesticide Chemical Code 202901
Ebivit
FeraCol
Granuvit D3
HMS1569E20
HMS2092M12
HSDB 820
I05-0041
Irradiated 7-dehydrocholesterol
KBio1_001220
KBio2_001643
KBio2_004211
KBio2_006779
KBio3_001628
KBioGR_001602
KBioSS_001643
LMST03020001
LMST03020219
LMST03020220
LMST03020221
LS-1570
LS-825
LT00244775
MEGxm0_000458
Micro-dee
MolPort-001-740-051
MolPort-001-785-972
MolPort-003-666-021
MolPort-004-946-964
NCGC00016301-01
NCGC00017328-01
NCGC00091072-01
NCGC00142511-01
NCGC00159331-02
NCGC00159331-04
NCGC00178668-01
NCGC00179565-01
NCGC00179565-02
NEO Dohyfral D3
NSC 375571
NSC-375571
NSC375571
Oleovitamin D3
Prestwick0_000429
Prestwick1_000429
Prestwick2_000429
Prestwick3_000429
Prestwick_63
Provitamine
Provitina
Quintox
Rampage
Ricketon
SMP1_000068
SPBio_001298
SPBio_002357
SR-05000001559
SR-05000001559-3
ST057172
SpecPlus_000180
Spectrum2_001369
Spectrum3_000764
Spectrum4_001201
Spectrum_001163
TNP00266
Trivitan
UNII-1C6V77QF41
UPCMLD-DP152
UPCMLD-DP152:001
VITAMIN D
VITAMIN D3 POWDER
VITAMIN_D3
Vi-De3
Vi-de-3-hydrosol
VidDe-3-hydrosol
Videkhol
Vigantol
Vigorsan
Vitamin D3
Vitamin D3 emulsifiable
Vitinc Dan-Dee-3
ZINC04474460
ZINC04492874
ZINC04492875
ZINC04492876
ZINC04492878
bmse000507
calciol
cholecalciferol
delta-D
vitamin d-3
3vitamin dPhase 31524
4VitaminsPhase 33857
5Bone Density Conservation AgentsPhase 32600
6Trace ElementsPhase 33900
7ErgocalciferolsPhase 3923
8MicronutrientsPhase 33901
9CalciferolNutraceuticalPhase 31074
10Vitamin D2NutraceuticalPhase 3923
11VaccinesPhase 1, Phase 26085
12Glutamic AcidNutraceuticalPhase 1, Phase 2201
13Immunologic FactorsPhase 118483
14KrestinPhase 1189

Interventional clinical trials:

(show all 14)
idNameStatusNCT IDPhase
1Maternal Vitamin D for Acute Respiratory Infections in InfancyActive, not recruitingNCT02388516Phase 3
2A Study to Evaluate the Safety, Tolerability, Immunogenicity and Vaccine-like Viral Shedding of MEDI-534, Against Respiratory Syncytial Virus (RSV) and Parainfluenza Virus Type 3 (PIV3), in Healthy 6 to <24 Month-old Children and in 2 Month-old InfantsCompletedNCT00686075Phase 1, Phase 2
3A Phase 1/2A Study to Evaluate the Safety, Immunogenicity, and Shedding of MEDI-560 in Infants 1 to < 12 Months of AgeTerminatedNCT00508651Phase 1, Phase 2
4Safety of and Immune Response to a Cow/Human Parainfluenza Virus Vaccine (rB/HPIV3) in Healthy Infants, Children, and AdultsCompletedNCT00366782Phase 1
5Study to Evaluate the Safety of MEDI-534 Vaccine Against Respiratory Syncytial Virus (RSV) and Parainfluenza Virus Type 3 (PIV3) in Healthy ChildrenCompletedNCT00345670Phase 1
6Evaluating the Safety and Immunogenicity of a Human Parainfluenza Type 3 (HPIV3) Virus Vaccine in Infants and ChildrenCompletedNCT01254175Phase 1
7Safety and Tolerability Study to Evaluate MEDI-534 in Children 6 to < 24 Months of AgeCompletedNCT00493285Phase 1
8Safety of and Immune Response to Recombinant Live Attenuated Parainfluenza Type 3 Virus Vaccine in Healthy Infants and ChildrenCompletedNCT01021397Phase 1
9Safety of and Immune Response to a Human Parainfluenza Virus Vaccine (rHPIV3cp45) in Healthy InfantsCompletedNCT00308412Phase 1
10Study to Evaluate MEDI-534 in Healthy AdultsCompletedNCT00111878Phase 1
11Safety of and Immune Response to Recombinant Live-Attenuated Parainfluenza Type 1 Virus VaccineCompletedNCT00641017Phase 1
12A Study to Assess the Safety of Live Intranasal Sendai Virus Vaccine in Children and ToddlersRecruitingNCT00186927Phase 1
13Evaluating the Safety of and Immune Response to a Human Parainfluenza Virus Type 3 Ebola Virus Vaccine (HPIV3-EbovZ GP) in Healthy AdultsActive, not recruitingNCT02564575Phase 1
14Collection and Testing of Respiratory SamplesCompletedNCT01302418

Search NIH Clinical Center for Parainfluenza Virus Type 3

Genetic Tests for Parainfluenza Virus Type 3

About this section

Anatomical Context for Parainfluenza Virus Type 3

About this section

MalaCards organs/tissues related to Parainfluenza Virus Type 3:

33
Bone, Brain, Lung, Testes, Kidney, Endothelial, T cells

Animal Models for Parainfluenza Virus Type 3 or affiliated genes

About this section

MGI Mouse Phenotypes related to Parainfluenza Virus Type 3:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes

Publications for Parainfluenza Virus Type 3

About this section

Articles related to Parainfluenza Virus Type 3:

(show top 50)    (show all 269)
idTitleAuthorsYear
1
Serum GDF-15 level in BehAset's disease: relationships between disease activity and clinical parameters. (27206990)
2016
2
NEW UNDERSTANDING OF NONCONVULSIVE STATUS EPILEPTICUS IN ADULTS: TREATMENTS AND CHANLLENGES. (26559043)
2015
3
Superficial siderosis of the central nervous system associated with incomplete dural closure following posterior fossa surgery: report of 3 cases. (26067619)
2015
4
Combining TNFSF15 and ASCA IgA can be used as a predictor for the stenosis/perforating phenotype of Crohn's disease. (24783249)
2014
5
Drug-related problems in type 2 diabetes mellitus patients with dyslipidemia. (24341672)
2013
6
Handedness and language learning disability differentially distribute in progressive aphasia variants. (24056533)
2013
7
Primary spinal leptomeningeal gliomatosis in a 3-year-old boy revealed with MRI and FDG PET/CT mimicking tuberculosis meningitis. (24076037)
2013
8
Risk of Congenital Malformations Among Offspring of Mothers and Fathers With Celiac Disease: A Nationwide Cohort Study. (24161347)
2013
9
A spontaneous epithelial-myoepithelial carcinoma of the submandibular gland in a sprague-dawley rat. (23723571)
2013
10
Protein disulfide isomerase and glutathione are alternative substrates in the one Cys catalytic cycle of glutathione peroxidase 7. (23454490)
2013
11
Kisspeptin: Role in reproduction and implications for infertility management. (23162367)
2012
12
Antibody responses to the immunodominant Cryptosporidium gp15 antigen and gp15 polymorphisms in a case-control study of cryptosporidiosis in children in Bangladesh. (21734132)
2011
13
Evaluation of the United States public health service guidelines for discontinuation of anticytomegalovirus therapy after immune recovery in patients with cytomegalovirus retinitis. (21742304)
2011
14
Bioabsorbable fixation of unstable osteochondritis dissecans lesions. (20595548)
2010
15
Serotonin as a physiological substrate for myeloperoxidase and its superoxide-dependent oxidation to cytotoxic tryptamine-4,5-dione. (19828014)
2010
16
Systemic vascular function, measured with forearm flow mediated dilatation, in acute and stable cerebrovascular disease: a case-control study. (20955612)
2010
17
Screening of growth hormone deficiency in short thalassaemic patients and effect of L-carnitine treatment. (22371726)
2010
18
Wegener's granulomatosis presenting with life-threatening lung hemorrhage in a 7-year-old child. (19777238)
2010
19
RASSF1A hypermethylation in pretreatment serum DNA of neuroblastoma patients: a prognostic marker. (19165202)
2009
20
Depolarization induces downregulation of DNMT1 and DNMT3a in primary cortical cultures. (18536530)
2008
21
Testicular sperm extraction in cancerous testicle in patients with azoospermia: a case report. (17172283)
2007
22
Downregulation of Bid is associated with PKCepsilon-mediated TRAIL resistance. (17186022)
2007
23
A contagious journey within a culture of complacency: the smallpox scare of 1962 in New York and Toronto. (18447310)
2007
24
New insights into RSK activation and hematopoietic cancer. (17785199)
2007
25
Examination of human tissue cytosols for expression of sulfotransferase isoform 1A2 (SULT1A2) using a SULT1A2-specific antibody. (15528404)
2005
26
An unusual case of bilateral submandibular sialolithiasis in a young female patient. (15850690)
2005
27
International registry for primary hyperoxaluria. (15961949)
2005
28
Coexistent rearrangements of c-MYC, BCL2, and BCL6 genes in a diffuse large B-cell lymphoma. (14979479)
2004
29
Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs. (15572716)
2004
30
Paralytic poliomyelitis caused by a vaccine-derived polio virus in an antibody-deficient Argentinean child. (12828159)
2003
31
No association between IL-10 promoter gene polymorphism and heart failure or rejection following cardiac transplantation. (11260510)
2001
32
Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product. (10385705)
1999
33
Differences in cellular infiltrate and extracellular matrix of chronic diabetic and venous ulcers versus acute wounds. (9804349)
1998
34
Pure congenital Foix-Chavany-Marie syndrome. (9352733)
1997
35
Apolipoprotein H levels in diabetic subjects: correlation with cholesterol levels. (9160818)
1997
36
Interactions of human alpha/beta and gamma/delta T lymphocyte subsets in shear flow with E-selectin and P-selectin. (8642261)
1996
37
Expression of SPARC in normal and fibrotic livers. (7875683)
1995
38
Acute carotid artery thrombosis after neck irradiation. (7933034)
1994
39
Benign rheumatoid nodule versus subcutaneous granuloma annulare: a diagnostic dilemma--are they the same entity? (8019538)
1994
40
Laser lithotripsy: a preliminary study on its application for sialolithiasis. (7947565)
1994
41
Transitional cell carcinoma of the renal pelvis with choriocarcinomatous differentiation. Immunohistochemical and immunoelectron microscopic assessment of human chorionic gonadotropin production by transitional cell carcinoma of the urinary bladder. (8448745)
1993
42
Regulated and constitutive secretion of distinct molecular forms of acetylcholinesterase from PC12 cells. (8308056)
1993
43
SHBG serum level in women with endometriosis before, during and after long-term danazol therapy]. (8462828)
1993
44
Pulmonary sarcoidosis and corticosteroids. (8503575)
1993
45
Activity of glucocerebrosidase in extracts of different cell types from type 1 Gaucher disease patients. (2225530)
1990
46
Cholecystokinin does not stimulate prosomatostatin-derived peptides in man. (1970830)
1990
47
Sequence identity between the alpha 2-macroglobulin receptor and low density lipoprotein receptor-related protein suggests that this molecule is a multifunctional receptor. (1698775)
1990
48
Platelet-derived growth factor: identification of constituent polypeptide chains. (7073684)
1982
49
Keratoconjunctivitis sicca following excision of a dermolipoma of the lacrimal gland. (736416)
1978
50
Plasma TSH levels in endemic goiter subjects. (4193197)
1970

Variations for Parainfluenza Virus Type 3

About this section

Expression for genes affiliated with Parainfluenza Virus Type 3

About this section
Search GEO for disease gene expression data for Parainfluenza Virus Type 3.

Pathways for genes affiliated with Parainfluenza Virus Type 3

About this section

Pathways related to Parainfluenza Virus Type 3 according to GeneCards Suite gene sharing:

idSuper pathwaysScoreTop Affiliating Genes
19.5DDX58, IFNB1

GO Terms for genes affiliated with Parainfluenza Virus Type 3

About this section

Biological processes related to Parainfluenza Virus Type 3 according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1response to virusGO:00096159.5DDX58, IFNB1

Sources for Parainfluenza Virus Type 3

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet